The Innovator IBD Breakout Opportunities ETF (BOUT) is a dynamic investment vehicle that targets the total market with a unique focus on size and style, specifically designed to capitalize on breakout opportunities within a broad-based niche. This ETF seeks to harness growth potential by tapping into companies poised for significant market movements, as identified by Investor's Business Daily's proprietary methodology. BOUT is crafted for investors looking to diversify their portfolios with a growth-oriented strategy, offering exposure to a curated selection of stocks that exhibit the potential for robust performance. By focusing on size and style within the total market spectrum, BOUT provides a strategic blend of innovation and market acumen, aiming to deliver value through a disciplined approach to identifying and capitalizing on emerging market trends. This ETF is an ideal option for investors eager to explore the dynamic interplay of market forces and growth opportunities, making it a compelling choice for those seeking to enhance their investment landscape with a forward-thinking perspective.
Asset Class
Equity
Region
North America
Issuer
Innovator
Index Tracked
IBD Breakout Stocks Total Return
Ticker Symbol
BOUT
Innovator IBD Breakout Opportunities ETF (BOUT) Fund Flow Chart
Innovator IBD Breakout Opportunities ETF (BOUT) 1 year Net Flows: -$2M
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.